Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Gross Margin (2022)

Historic Gross Margin for Pasithea Therapeutics (KTTA) over the last 1 years, with Q4 2022 value amounting to 100.54%.

  • Pasithea Therapeutics' Gross Margin changed N/A to 100.54% in Q4 2022 from the same period last year, while for Dec 2022 it was 76.74%, marking a year-over-year change of. This contributed to the annual value of 76.74% for FY2022, which is 914300.0% up from last year.
  • Per Pasithea Therapeutics' latest filing, its Gross Margin stood at 100.54% for Q4 2022.
  • Pasithea Therapeutics' 5-year Gross Margin high stood at 100.54% for Q4 2022, and its period low was 11.19% during Q2 2022.